Literature DB >> 12655345

HCV immunology--death and the maiden T cell.

C Willberg1, E Barnes, P Klenerman.   

Abstract

Cellular immune responses play an important role in the control of hepatitis C virus (HCV), although in the majority of cases they ultimately fail. We examine the mechanisms by which virus-specific T cells may interact with a cell that is infected with HCV and how this interaction may explain the success and failure of the immune response. As an infected cell presenting foreign antigen, the hepatocyte will interact with a large number of lymphocytes, both by direct cell to cell contact and by indirect means through the secretion of cytokines and chemokines. These interactions may lead on the one hand to the death of infected hepatocytes or suppression of viral replication and on the other hand to the death of T lymphocytes or down regulation of their function. We suggest that activation of lymphocytes in lymphoid organs leads to generation of effector T cells (positive loop), while at the same time presentation of antigen in the liver either on hepatocytes or other specialised antigen presenting cells depresses these responses (negative loop). This model helps to explain both the specific phenotype and low frequencies of HCV specific CTL in chronic infection, through early elimination of cells before expansion and maturation can occur. The outcome of HCV infection is likely to result from the early balance between these two simultaneous loops.

Entities:  

Mesh:

Year:  2003        PMID: 12655345     DOI: 10.1038/sj.cdd.4401122

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  13 in total

1.  Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses.

Authors:  Andreas Zafiropoulos; Eleanor Barnes; Clive Piggott; Paul Klenerman
Journal:  Proc Biol Sci       Date:  2004-02-07       Impact factor: 5.349

2.  Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection.

Authors:  Julio Granados-Montiel; Joaquin Zúñiga; Jose Azocar; Edmond J Feris; Daniel Terreros; Charles E Larsen; Olga P Clavijo; Alfredo Cruz-Lagunas; Derek Middleton; Chester A Alper; Janardan P Pandey; Edmond J Yunis
Journal:  Immunobiology       Date:  2010-11-05       Impact factor: 3.144

3.  Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.

Authors:  Ayaz M Majid; Heather Ezelle; Sangeeta Shah; Glen N Barber
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection.

Authors:  Simon M Rushbrook; Scott M Ward; Esther Unitt; Sarah L Vowler; Michaela Lucas; Paul Klenerman; Graeme J M Alexander
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.

Authors:  Shuping Wang; Rico Buchli; Jennifer Schiller; Jianen Gao; Rodney S VanGundy; William H Hildebrand; David D Eckels
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

Review 6.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 7.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system.

Authors:  John R Lukens; Joseph S Dolina; Taeg S Kim; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

9.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.

Authors:  David G Bowen; Monica Zen; Lauren Holz; Thomas Davis; Geoffrey W McCaughan; Patrick Bertolino
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 10.  Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.

Authors:  Juan-Ramón Larrubia; Selma Benito-Martínez; Joaquín Miquel; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.